apelin-13-peptide has been researched along with Dementia--Vascular* in 1 studies
1 other study(ies) available for apelin-13-peptide and Dementia--Vascular
Article | Year |
---|---|
Apelin receptor homodimer inhibits apoptosis in vascular dementia.
Apelin receptor (APJ), a member of family A of the G protein-coupled receptors (GPCRs), is a potential pharmaceutical target for diseases of the nervous system. Our previous work revealed that human APJ can form a homodimer that has different functional characteristics than the monomer. To investigate the effects of APJ homodimers on neuroprotection in vascular dementia (VD), we established VD model in rats and treated the animals by injecting apelin-13 into the lateral ventricle. In addition, we established an oxygen-glucose deprivation/reoxygenation (OGD/R) model in SH-SY5Y cells treated with apelin-13. After apelin-13 stimulation in the VD rat, the level of APJ and APJ homodimer were elevated. Furthermore, APJ homodimer decreased the level of cleaved caspase-3 and cleaved caspase-9 via the Gα Topics: Apelin Receptors; Apoptosis; Cell Death; Dementia, Vascular; Humans; Intercellular Signaling Peptides and Proteins; Neurons; Receptors, G-Protein-Coupled; Signal Transduction | 2021 |